Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For NVDA.NE
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Weak
17%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -15.39 3.53 4.17
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -20.74 0.21 0.26
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 15.78 19.96 17.24
Cash 22.51 12.77 10.42
Capex -47.10 -0.15 -0.10
Free Cash Flow 34.85 6.08 4.51
Revenue 19.31 10.58 8.87
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 3.14 0.78 0.76
Operating Margin 5.41 0.65 0.62
ROA 3.30 0.19 0.19
ROE 5.94 0.30 0.29
ROIC 9.91 0.24 0.22
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of NVDA.NE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of NVDA.NE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of NVDA.NE is permitted for members.